INT194974

Context Info Confidence 0.15 First Reported 2006 Last Reported 2006 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.53 Pain Relevance 0.17

cytosol (Alox5) nuclear envelope (Alox5) oxidoreductase activity (Alox5) nucleus (Alox5) cytoplasm (Alox5)

Alox5 (Rattus norvegicus)

Pain Link Frequency Relevance Heat ischemia 21 95.52 ketamine 1 44.64 vagus nerve 1 32.24 Inflammation 22 19.68 Inflammatory mediators 4 15.24 Bioavailability 4 5.00 Inflammatory response 3 5.00 cytokine 2 5.00 cINOD 1 5.00 anesthesia 1 5.00

Disease Link Frequency Relevance Heat Cv Unclassified Under Development 13 95.52 Body Weight 2 75.12 Brain Hemorrhage 8 64.88 Middle Cerebral Artery Infarction 7 60.64 Injury 22 50.00 Stroke 17 21.56 Brain Injury 1 20.56 INFLAMMATION 30 19.68 Infarction 8 5.00 Death 6 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

In the treatment group, the rats were given 5-LOX inhibitor, dissolved in sterile DMSO (15 ?

Regulation (given) of 5-LOX Binding (inhibitor) of

1) Confidence 0.15 Published 2006 Journal J Neuroinflammation Section Body Doc Link PMC1526713 Disease Relevance 0.53 Pain Relevance 0.17

General Comments

This test has worked.